Results 161 to 170 of about 40,111 (286)

Machine learning‐based prediction of bleeding risk in extracorporeal membrane oxygenation patients using transfusion as a surrogate marker

Transfusion, EarlyView.
Abstract Background The increasing use of extracorporeal membrane oxygenation (ECMO) has highlighted challenges in managing bleeding complications. Optimal transfusion strategies remain uncertain for this diverse patient group, necessitating accurate predictive tools.
Tadashi Kamio, Masaru Ikegami, Megumi Mizuno, Seiichiro Ishii, Hayato Tajima, Yoshihito Machida, Kiyomitsu Fukaguchi   +6 more
wiley   +1 more source

A prolonged activated partial thromboplastin time indicates poor short-term prognosis in patients with hepatic encephalopathy: insights from the MIMIC database. [PDF]

Front Med (Lausanne)
Zhan L, Yang Y, Nie B, Kou Y, Du S, Tian Y, Huang Y, Ye R, Huang Z, Luo B, Ge L, Ye S.   +11 more
europepmc   +1 more source

P1659Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment [PDF]

, 2017
T. Moumneh, Y. Malledan, A. Calmes, E. Lacour, Prateek Roy   +4 more
openalex   +1 more source

Incorrect blood typing and mis‐transfusion due to low‐titer group O whole blood resuscitation

Transfusion, EarlyView.
Abstract Background Resuscitation strategies for massive hemorrhage increasingly involve the use of low‐titer group O whole blood (LTOWB) due to evidence suggesting improved patient outcomes. However, the potential risk of incorrect ABO typing following LTOWB administration, possibly leading to mis‐transfusion, remains insufficiently explored.
Miriam Brown, Deva Sharma, Kaycie Atchison, Bradley M. Dennis, Erika Hall, Angela Mueller, Christine Schaeffer, Jessica E. Schucht, Jill R. Streams, Toufik Tahiri, Garrett S. Booth, Jeremy W. Jacobs   +11 more
wiley   +1 more source

Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study. [PDF]

Kidney Med
Wang LS, Ertmann E, Feldman E, Kossoff M, Lu B, Lin JC, Pishko A, Redfield R, Leonberg-Yoo A, Cuker A.   +9 more
europepmc   +1 more source

Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay. [PDF]

Int J Mol Sci, 2022
Billoir P, Elie T, Levy JH, Besnier E, Dureuil B, Veber B, Le Cam-Duchez V, Clavier T.   +7 more
europepmc   +1 more source

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform [PDF]

, 2018
Haruna Katayama, Takeshi Matsumoto, Hideo Wada, Naoki Fujimoto, Junki Toyoda, Yasunori Abe, Kohshi Ohishi, Yoshiki Yamashita, Makoto Ikejiri, Koji Habe, Naoyuki Katayama   +10 more
openalex   +1 more source

The evaluation of prothrombin time and activated partial thromboplastin time among diabetic and healthy controls in Africa: systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Getu F, Alemayehu E, Tesfaye A, Genanew B, Walle M.   +4 more
europepmc   +1 more source

An Agreement Study Between Point-of-Care and Laboratory Activated Partial Thromboplastin Time for Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation. [PDF]

Front Med (Lausanne), 2022
Teng Y, Yan S, Liu G, Lou S, Zhang Y, Ji B.   +5 more
europepmc   +1 more source

A case of syphilis presenting with prolonged etiology‐unrevealed fever, accompanying activated partial thromboplastin time prolongation [PDF]

, 2018
Kazuhiro Yasuo
openalex   +1 more source